Results 151 to 160 of about 5,163,498 (211)

Identification of the Polo-like kinase substrate required for homologous synapsis. [PDF]

J Cell Biol
Gold AL, Hurlock ME, Guevara AM, Isenberg LYZ, Kim Y.   +4 more
europepmc   +1 more source

High expression of polo-like kinase 4 predicts worse progression-free survival in diffuse large B cell lymphoma patients treated with R-CHOP. [PDF]

World J Surg Oncol
Xu D, Ran Q, Xu B, Wang Q, Geng T.
europepmc   +1 more source

Polo-like kinase inhibitors increase AAV production by halting cell cycle progression. [PDF]

Mol Ther Methods Clin Dev
Fisher K, Grafton F, Ispaso F, Tworig J, Derler R, Sonntag F, Hörer M, Schulze A, Reid CA, Mandegar MA.   +9 more
europepmc   +1 more source

Polo-like Kinase 1 Expression as a Biomarker in Colorectal Cancer: A Retrospective Two-Center Study. [PDF]

Biomedicines
Jajac Brucic L, Bisof V, Soce M, Skelin M, Krecak I, Nadinic A, Vrbicic B, Puljiz Z, Hancic S, Gasparov S.   +9 more
europepmc   +1 more source

Nonessential kinetochore proteins contribute to meiotic chromosome condensation through polo-like kinase. [PDF]

Mol Biol Cell
Trakroo D, Agarwal P, Alekar A, Ghosh SK.   +3 more
europepmc   +1 more source

Polo-like kinase 1 inactivation enhances PI3K inhibition-mediated apoptosis of NOTCH1-mutant head and neck squamous cell carcinoma. [PDF]

Cancer Lett
Shah PA, Mazumdar T, Ghosh S, Yapindi L, Powell RT, Park YS, Shen L, Fernandez AM, Stephan CC, Wang J, Sikora AG, Kazi J, Frederick MJ, Johnson FM.   +13 more
europepmc   +1 more source

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer. [PDF]

Mol Cancer Ther
Nouri M, Varkaris A, Ridinger M, Dalrymple SL, Dennehy CM, Isaacs JT, Einstein DJ, Brennen WN, Balk SP.   +8 more
europepmc   +1 more source

Only Infant MLL-Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib. [PDF]

Int J Mol Sci
Fischer J, Erkner E, Radszuweit P, Hentrich T, Keppeler H, Korkmaz F, Schulze-Hentrich J, Fitzel R, Lengerke C, Schneidawind D, Schneidawind C.   +10 more
europepmc   +1 more source

Polo-like Kinase 1 Inhibitors Demonstrate In Vitro and In Vivo Efficacy in Preclinical Models of Small Cell Lung Cancer. [PDF]

Cancers (Basel)
Zhang G, Pannucci A, Ivanov AA, Switchenko J, Sun SY, Sica GL, Liu Z, Huang Y, Schmitz JC, Owonikoko TK.   +9 more
europepmc   +1 more source